Docusign (NASDAQ:DOCU) Director Anna Marrs Sells 363 Shares of Stock

Docusign Inc. (NASDAQ:DOCU) Director Anna Marrs sold 363 shares of the business’s stock in a transaction dated Friday, June 5th. The stock was sold at an average price of $49.42, for a total value of $17,939.46. Following the transaction, the director directly owned 12,977 shares of the company’s stock, valued at approximately $641,323.34. This represents a 2.72% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Anna Marrs also recently made the following trade(s):

• On Tuesday, June 2nd, Anna Marrs sold 365 shares of Docusign stock. The stock was sold at an average price of $55.04, for a total value of $20,089.60.

Docusign Stock Performance

Shares of Docusign stock opened at $47.26 on Friday. Docusign Inc. has a one year low of $40.16 and a one year high of $86.65. The company has a market cap of $9.18 billion, a PE ratio of 30.69, a P/E/G ratio of 1.94 and a beta of 0.92. The business has a 50-day simple moving average of $47.76 and a 200-day simple moving average of $54.16.

Docusign (NASDAQ:DOCU) last announced its quarterly earnings data on Thursday, June 4th. The company reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $1.00 by $0.09. Docusign had a return on equity of 17.16% and a net margin of 9.59%.The business had revenue of $830.24 million during the quarter, compared to the consensus estimate of $824.71 million. During the same period in the previous year, the company posted $0.90 earnings per share. The business’s revenue for the quarter was up 8.7% on a year-over-year basis. On average, sell-side analysts predict that Docusign Inc. will post 1.76 earnings per share for the current fiscal year.

Docusign announced that its board has authorized a stock repurchase program on Tuesday, March 17th that allows the company to buyback $2.00 billion in shares. This buyback authorization allows the company to reacquire up to 21% of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s leadership believes its shares are undervalued.

Institutional Investors Weigh In On Docusign

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Nordea Investment Management AB lifted its stake in Docusign by 3.8% in the fourth quarter. Nordea Investment Management AB now owns 1,198,634 shares of the company’s stock valued at $82,502,000 after buying an additional 43,810 shares during the last quarter. Step Capital Management Pte. Ltd. purchased a new stake in Docusign in the fourth quarter valued at approximately $2,052,000. Retirement Systems of Alabama lifted its stake in Docusign by 4.9% in the fourth quarter. Retirement Systems of Alabama now owns 544,473 shares of the company’s stock valued at $37,242,000 after buying an additional 25,367 shares during the last quarter. Envestnet Asset Management Inc. lifted its stake in Docusign by 11.1% in the third quarter. Envestnet Asset Management Inc. now owns 312,859 shares of the company’s stock valued at $22,554,000 after buying an additional 31,334 shares during the last quarter. Finally, South Dakota Investment Council lifted its stake in Docusign by 140.6% in the third quarter. South Dakota Investment Council now owns 53,373 shares of the company’s stock valued at $3,848,000 after buying an additional 31,192 shares during the last quarter. Hedge funds and other institutional investors own 77.64% of the company’s stock.

Trending Headlines about Docusign

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: DocuSign beat first-quarter expectations, posting adjusted EPS of $1.09 versus $1.00 expected and revenue of $830.2 million versus $823.2 million estimated, with sales up 8.7% year over year. DocuSign Beats Fiscal Q1 Estimates, but IAM Traction Remains in Focus, RBC Says
• Positive Sentiment: The company said adoption of its AI-powered Intelligent Agreement Management platform is improving, and it raised full-year revenue guidance slightly, indicating demand remains healthy. DocuSign Nudges Revenue Outlook Higher After First-Quarter Profit Rises
• Neutral Sentiment: Analyst commentary remains mixed, with Wedbush lowering its price target to $58 from $60 while keeping a neutral rating, and BTIG cutting its target to $60 from $70 but maintaining a buy rating.
• Neutral Sentiment: DocuSign also highlighted AI integrations, including ChatGPT and Codex, and continued share repurchases, which support the long-term story but were not enough to offset near-term guidance concerns. Docusign Inc (DOCU) Q1 2027 Earnings Call Highlights
• Negative Sentiment: Shares moved lower because the full-year outlook did not meaningfully exceed Wall Street expectations, dampening enthusiasm despite the earnings beat and prompting a “sell-the-news” reaction. DocuSign shares fall despite Q1 beat as guidance disappoints investors
• Negative Sentiment: Investors also appear to be focusing on whether DocuSign can accelerate growth beyond the low-double-digit range, as recent reports say the outlook “left investors looking for stronger signs of accelerating growth.” DocuSign stock falls as cautious outlook overshadows earnings beat

Wall Street Analysts Forecast Growth

DOCU has been the subject of several recent analyst reports. Wedbush decreased their target price on Docusign from $60.00 to $58.00 and set a “neutral” rating for the company in a research note on Friday. Jefferies Financial Group boosted their target price on Docusign from $45.00 to $50.00 and gave the stock a “hold” rating in a research note on Friday. Robert W. Baird decreased their target price on Docusign from $75.00 to $55.00 and set a “neutral” rating for the company in a research note on Wednesday, March 18th. Bank of America initiated coverage on Docusign in a research note on Tuesday, March 31st. They set an “underperform” rating and a $52.00 target price for the company. Finally, Wells Fargo & Company decreased their target price on Docusign from $60.00 to $55.00 and set an “equal weight” rating for the company in a research note on Friday. Three research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Docusign currently has a consensus rating of “Hold” and a consensus price target of $60.27.

About Docusign

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.